Investing Profile

Neil Exter

InvestorVC
Retired Partner at Third Rock Ventures
Photo of Neil Exter, Third Rock Ventures

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Stanford University Network
1253 CONNECTIONS
Cornell University Network
329 CONNECTIONS
Hewlett Packard Enterprise Network
146 CONNECTIONS
Third Rock Ventures Network
50 CONNECTIONS
Third Rock Ventures Network
50 CONNECTIONS
cb
$100K - $5.0M
$1.5M
9
$770M
CompanyStageDateRound SizeTotal Raised
Thrive Earlier Detection
Series BJul 2020$260M
Series AMay 2019$110M
$370M
Co-investors: Mike Pellini (Section 32), Christoph Lengauer (Third Rock Ventures), Steve Kafka (S32), Eli Casdin (Casdin Capital, LLC)
CytomX Therapeutics
Series CJan 2015$20M
Series BJul 2012$11M
Series BSep 2010$30M
$61M
Co-investors: Tim Shannon (Canaan Partners), Charles Homcy (Third Rock Ventures)
Soffio Medical
SeedDec 2013$3M
$3M
Co-investors: Paul LaViolette (SV Health Investors)
Cibiem, Inc.
Series AOct 2012$10M
SeedDec 2010$3M
$13M
Lotus Tissue Repair
Series AJun 2011$26M
$26M
Co-investors: Philip Reilly (Third Rock Ventures)
Sales Development et al Hewlett Packard EnterprisePresent
Project Leader Stellar ComputerPresent
Consultant Corporate DecisionsPresent
VP Business Development KPNPresent
EVP The Macgregor GroupPresent
VP Business Development Takeda OncologyPresent
Chief Business Officer Alantos PharmaceuticalsPresent
CEO Flexplay TechnologiesPresent
Partner Third Rock VenturesPresent
Retired Partner Third Rock VenturesPresent
Cornell University BS Electrical Engineering
Stanford University MS Electrical Engineering
Sign in with Google →
Sign in with Google →